查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1976590

內分泌檢測市場：按類型、產品類型、檢體類型、技術、疾病類型和最終用戶分類－2026-2032年全球預測

Endocrine Testing Market by Type, Product Type, Sample Type, Technology, Disease Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，內分泌檢測市場價值將達到 108.8 億美元，到 2026 年將成長至 117.8 億美元，到 2032 年將達到 194.2 億美元，複合年成長率為 8.61%。

主要市場統計數據
基準年 2025 108.8億美元
預計年份：2026年 117.8億美元
預測年份 2032 194.2億美元
複合年成長率 (%) 8.61%

本報告重點闡述了關鍵促進因素、新興技術和市場基礎，將荷爾蒙檢測置於現代醫療策略的前沿。

內分泌檢測已成為現代醫學的重要支柱，為多種荷爾蒙失調的診斷和治療提供支持。檢測靈敏度的提高，以及對內分泌病理學更深入的理解，使得這些檢測從常規臨床工具躍升為促進以病人為中心的醫療服務的策略性手段。糖尿病、甲狀腺功能障礙和腎上腺疾病等疾病的日益普遍，使得準確可靠的診斷變得特別迫切。同時，個人化醫療的發展也要求檢測實驗室和檢測研發人員提供快速、多樣化且微創的解決方案。

本檢驗了技術創新、監管改革和以病人為中心的照護模式為內分泌診斷帶來的變革性變化。

近年來，在尖端技術創新和不斷變化的監管要求的推動下，內分泌診斷領域經歷了翻天覆地的變化。串聯式質譜質譜和高通量免疫檢測在檢查室工作流程的應用，顯著提升了診斷的準確性和處理能力。同時，全球監管機構不斷實施更嚴格的檢驗要求和品質標準，迫使生產商在合規和文件編制流程方面投入巨資。

在經濟環境波動的情況下，評估美國關稅到 2025 年對內分泌檢測供應鏈和市場營運的累積影響。

隨著2025年進口試劑、設備和配件關稅結構的調整，內分泌檢測供應鏈的韌性備受關注。檢測實驗室和設備供應商面臨不斷上漲的投入成本，被迫全面檢視其籌資策略。許多機構正在加速供應商網路多元化，並建立區域分銷中心，以降低成本上漲和運輸延誤的風險。

揭示了影響市場的關鍵細分見解，包括測試類型、產品類型、檢體介質、技術、疾病分類和最終用戶。

對市場區隔的詳細分析揭示了內分泌診斷生態系統中各種檢測類型和應用領域的複雜結構。皮質醇測定仍然是評估腎上腺功能的重要工具，而硫酸去氫表雄酮（DHEA-S）檢測在評估腎上腺雄激素生成的重要性日益凸顯。雌二醇測定是生殖健康監測的基礎，人類絨毛膜促性腺激素分泌（hCG）檢測則有助於不孕症的診治和懷孕後續觀察。胰島素測定對於血糖控制至關重要，性荷爾蒙譜檢測可提供全面的內分泌分析，而甲狀腺刺激素）分析則是甲狀腺疾病診治的基礎。

本報告重點分析了美洲、歐洲、中東和非洲以及亞太地區的關鍵區域趨勢，揭示了清晰的需求模式、採用率和成長要素。

內分泌檢測領域的區域趨勢呈現出顯著差異，反映了不同服務提供者在監管環境、報銷機制和患者群體特徵方面的差異。在美洲，完善的報銷機制和成熟的檢測網路促進了先進檢測平台的快速部署。學術機構與私人企業之間的合作研究舉措進一步強化了創新管道，推動了新型診斷方法的試點應用。

主要產業參與者概況：策略聯盟、創新組合和不斷演變的競爭優勢塑造了全球內分泌檢測市場

內分泌診斷領域的主要企業正透過策略聯盟、產品組合精簡和技術創新來加強自身差異化優勢。現有試劑和儀器製造商正與生物製藥公司合作，共同開發伴隨診斷產品；同時，診斷專家也在整合數位健康平台，以簡化數據管理和遠端監測流程。

為內分泌診斷領域的產業領導者提供關於技術整合、策略夥伴關係和新興市場拓展的實用建議。

我們鼓勵業界領導者採用靈活的平台，實現免疫檢測和質譜聯用，加速下一代技術的整合。這種整合將簡化工作流程，降低整體擁有成本。同時，它也將促進與契約製造和區域分銷商的策略夥伴關係，降低供應鏈風險，並助力企業快速進入高成長市場。

詳細介紹採用綜合調查方法，結合一手訪談、二手分析和資料三角驗證，確保對市場有深入的洞察。

本分析採用嚴謹的混合方法研究設計，確保全面覆蓋和分析準確性。主要研究工作包括透過對高階主管、臨床實驗室經理、關鍵意見領袖 (KOL) 和採購專家進行結構化訪談來收集見解。這些訪談揭示了整個價值鏈中目前面臨的營運挑戰、未滿足的需求和策略重點。

總結觀點，重點闡述策略需求、未來前景和引領全球內分泌檢測發展的綜合創新。

內分泌檢測市場正處於轉折點，技術的快速進步、法規環境的不斷變化以及患者期望的演變共同作用，重新定義了診斷模式。細分市場分析突顯了臨床檢查室、研究機構和照護現場提供者的不同需求，而區域洞察則強調了適應性打入市場策略的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 內分泌檢測市場：依類型分類

  • 皮質醇測試
  • 脫氫表雄酮硫酸酯（DHEAS）檢測
  • 雌二醇 (E2) 檢測
  • 人類絨毛膜促性腺激素分泌(hCG) 荷爾蒙檢測
  • 胰島素測試
  • 性荷爾蒙檢測
  • 甲狀腺刺激素（TSH）檢測

第9章 內分泌檢測市場：依產品類型分類

  • 裝置
    • 層析法系統
    • 免疫檢測分析儀
    • 質譜系統
  • 試劑和試劑盒
    • 校正試劑
    • 管理材料
    • 診斷試劑盒
  • 軟體和服務
    • 資訊解決方案
    • 維護服務

第10章 依檢體類型分類的內分泌檢測市場

  • 血
  • 唾液
  • 尿

第11章 內分泌檢測市場：依技術分類

  • 臨床化學
  • 免疫檢測
  • 單株和多株抗體技術
  • 感測器技術
  • 串聯式質譜質譜法

第12章 內分泌檢測市場：依疾病類型分類

  • 腎上腺疾病
    • 愛迪生氏症
    • 庫欣氏症候群
  • 糖尿病
  • 性腺疾病
    • 性腺功能減退
    • 卵巢症候群
  • 甲狀腺功能障礙
    • 甲狀腺功能亢進
    • 甲狀腺機能低下症

第13章 內分泌檢測市場：依最終用戶分類

  • 學術機構
  • 診斷檢查室
  • 醫院和診所
  • 研究機構

第14章 內分泌檢測市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 內分泌檢測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 內分泌檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國內分泌檢測市場

第18章：中國內分泌檢測市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc
  • BioCheck Inc.
  • Biogenix Inc. Pvt. Ltd
  • bioMerieux SA
  • Blueprint Genetics Oy
  • Creative Diagnostics
  • Danaher Corporation
  • Diagnostic Automation/Cortez Diagnostics Inc.
  • DiaSorin SpA
  • Eagle Biosciences
  • EKF Diagnostics Holdings Plc
  • Eli Science Inc.
  • Eurofins Analytical Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Getein Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • MP Biomedicals, LLC
  • Ortho-Clinical Diagnostics, Inc.
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
Product Code: MRR-69324464D0E6

The Endocrine Testing Market was valued at USD 10.88 billion in 2025 and is projected to grow to USD 11.78 billion in 2026, with a CAGR of 8.61%, reaching USD 19.42 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 10.88 billion
Estimated Year [2026] USD 11.78 billion
Forecast Year [2032] USD 19.42 billion
CAGR (%) 8.61%

Positioning Hormone Testing at the Forefront of Modern Healthcare Strategies by Highlighting Key Drivers, Emerging Innovations, and Market Foundations

The field of endocrine testing has emerged as a critical pillar of modern healthcare, underpinning the diagnosis and management of a wide array of hormonal disorders. Advances in assay sensitivity, coupled with an expanding understanding of endocrine pathophysiology, have elevated these tests from routine clinical tools to strategic instruments that drive patient-centric care. Increasing prevalence of conditions such as diabetes, thyroid dysfunction, and adrenal disorders has heightened the urgency for precise, reliable diagnostics. At the same time, personalized medicine initiatives are placing new demands on laboratories and test developers to deliver rapid, multiplexed, and minimally invasive solutions.

As regulatory agencies refine guidelines and reimbursement frameworks evolve, manufacturers and laboratories are compelled to reimagine their operational models. Investments in digital health platforms, artificial intelligence for data interpretation, and point-of-care testing are reshaping traditional workflows. This introduction establishes the foundational context for an in-depth exploration of how technological breakthroughs, tariff dynamics, segmentation strategies, regional variations, and competitive intelligence are collectively redefining the endocrine testing landscape.

Examining Transformative Shifts in Endocrine Diagnostics Fueled by Technological Breakthroughs, Regulatory Reforms, and Patient-Centric Care Models

In recent years, the endocrine diagnostics sector has undergone seismic shifts driven by cutting-edge technological innovation and changing regulatory expectations. The integration of tandem mass spectrometry and high-throughput immunoassays into core laboratory workflows has unlocked new levels of assay precision and throughput. Concurrently, regulatory agencies around the world have introduced more stringent validation requirements and quality benchmarks, prompting manufacturers to invest heavily in compliance and documentation processes.

Beyond the bench, patient empowerment and home-based testing models have emerged as transformative forces. Direct-to-consumer test offerings for hormone monitoring and telehealth platforms have blurred the boundaries between clinical settings and at-home care, fostering a more participatory approach to disease management. As laboratories and instrument providers adapt, strategic partnerships with digital health firms and data analytics companies are becoming increasingly commonplace. The confluence of these technological and patient-centric revolutions is redirecting capital flows, reshaping R&D priorities, and setting the stage for an era of highly personalized endocrine care.

Assessing the Cumulative Impact of United States Tariffs on Endocrine Testing Supply Chains and Market Operations throughout 2025 in a Dynamic Economy

The imposition of new tariff structures on imported reagents, instruments, and ancillary supplies in 2025 has cast a spotlight on the resilience of endocrine testing supply chains. Laboratories and instrument vendors have faced elevated input costs, prompting a comprehensive reassessment of procurement strategies. Many organizations are accelerating the diversification of their supplier networks and establishing regional distribution hubs to mitigate the risk of cost pass-through and shipment delays.

In response to these pressures, domestic manufacturers have seized the opportunity to expand production capacities, collaborating with local distributors to ensure continuity of service. End-users have initiated safety-stock buffering plans and negotiated long-term agreements to secure preferential pricing. Although upfront capital expenditures have risen, these strategic adjustments are laying the groundwork for more agile, de-risked operations. Ultimately, the tariff-driven recalibration of supply chains is fostering a renewed emphasis on localization, strategic inventory management, and operational flexibility.

Unveiling Critical Segmentation Insights That Demonstrate How Test Types, Product Categories, Sample Mediums, Technologies, Disease Classifications, and End Users Shape the Market

A deep dive into market segmentation reveals a complex tapestry of test types and applications that underpin the endocrine diagnostics ecosystem. Cortisol assays continue to serve as essential tools for evaluating adrenal function, while dehydroepiandrosterone sulfate testing has gained prominence in assessing adrenal androgen output. Estradiol measurement remains a cornerstone of reproductive health monitoring, and human chorionic gonadotropin testing supports both fertility management and pregnancy surveillance. Insulin assays are indispensable for glycemic control, sex hormone panels provide comprehensive endocrine profiling, and thyroid stimulating hormone analysis is foundational to thyroid disease management.

The instrumentation and consumable landscape is equally multifaceted. Chromatography systems, immunoassay analyzers, and mass spectrometry platforms represent the primary instrument categories driving laboratory modernization. Complementing these instruments, calibrators, control materials, and diagnostic kits enable rigorous quality assurance and assay standardization. Informatics solutions and maintenance services provide the digital infrastructure and technical support necessary to optimize uptime and data integrity.

Sample medium diversity further enriches testing approaches, encompassing blood draws, saliva collection, and urine samples to accommodate both conventional laboratory protocols and emerging at-home testing models. Underlying these modalities, a spectrum of technological platforms-including clinical chemistry, immunoassay, monoclonal and polyclonal antibody technologies, sensor innovations, and tandem mass spectrometry-delivers unparalleled sensitivity, specificity, and throughput.

Disease-centric segmentation highlights distinct demand drivers. The adrenal disorder segment, including Addison's disease and Cushing's syndrome, requires specialized assays for cortisol and adrenal androgens. Diabetes monitoring leverages insulin and related metabolic markers, whereas gonadal disorder evaluation, covering hypogonadism and polycystic ovary syndrome, relies on comprehensive sex hormone panels. Thyroid dysfunction analysis, spanning hyperthyroidism and hypothyroidism, centers on the precise quantification of thyroid stimulating hormone.

Finally, the end-user landscape spans academic institutions pursuing basic research, diagnostic laboratories implementing high-volume workflows, hospitals and clinics integrating point-of-care solutions, and research institutes driving translational discovery. Each segment presents unique operational requirements and strategic priorities, underscoring the importance of tailored solutions and collaboration across the value chain.

Highlighting Key Regional Dynamics across the Americas, Europe Middle East Africa, and Asia Pacific to Reveal Distinct Demand Patterns, Adoption Rates, and Growth Drivers

Regional dynamics within the endocrinology testing sphere exhibit pronounced diversity as operators navigate distinct regulatory landscapes, reimbursement frameworks, and patient demographics. In the Americas, well-established reimbursement pathways and mature laboratory networks facilitate rapid adoption of advanced assay platforms. Collaborative research initiatives between academic centers and commercial entities further bolster innovation pipelines and enable pilot deployments of novel diagnostic modalities.

The Europe, Middle East, and Africa region presents a heterogeneous tapestry of regulatory environments, from the European Union's harmonized directives to varied approval processes across Middle Eastern and African nations. This mosaic compels manufacturers to pursue adaptive market entry strategies, leveraging local partnerships and regulatory expertise. High population growth in certain markets augments demand for cost-effective, point-of-care solutions, while established institutions in Western Europe continue to demand high-precision laboratory instrumentation.

Across Asia-Pacific, rapid economic growth and expanding healthcare infrastructure are driving increased diagnostic investments. In countries with burgeoning middle-class populations, there is notable uptake of minimally invasive and at-home testing options. Governmental initiatives aimed at enhancing rural healthcare access are stimulating deployment of portable immunoassay systems and integrated telehealth platforms. Simultaneously, major regional manufacturers are investing in R&D to develop localized solutions that address endemic endocrine health challenges and align with national healthcare priorities.

Profiling Leading Industry Players to Showcase Strategic Collaborations, Innovation Portfolios, and Competitive Advances Shaping the Global Endocrine Testing Arena

Leading participants in the endocrine diagnostics arena are intensifying efforts to differentiate through strategic alliances, portfolio rationalization, and technological innovation. Established reagent and instrument providers are forging collaborations with biopharmaceutical companies to co-develop companion diagnostics, while diagnostics specialists are integrating digital health platforms to streamline data management and remote monitoring.

In the instrument segment, vendors are focusing on modular designs that accommodate both routine immunoassays and high-resolution mass spectrometry on a unified platform. Reagent manufacturers are prioritizing assay miniaturization and reagent stability to support at-home testing and decentralized laboratory models. Meanwhile, informatics providers are enhancing interoperability, embedding artificial intelligence algorithms for result interpretation, and enabling real-time connectivity across multi-site networks.

Emerging players are capitalizing on niche opportunities by developing sensor-based handheld devices and disposable immunoassay cards tailored for field use. Consolidation activities remain prevalent, as companies seek to expand their geographic footprints and accelerate time to market for innovative assays. This dynamic competitive choreography ensures that strategic investments in R&D, partnerships, and platform extensions will continue to delineate market leadership.

Delivering Actionable Recommendations for Industry Leaders Focused on Technology Integration, Strategic Partnerships, and Emerging Market Expansion in Endocrine Diagnostics

Industry leaders should accelerate integration of next-generation technologies by adopting flexible platforms capable of simultaneous immunoassay and mass spectrometry analyses. Such convergence will streamline workflows and lower total cost of ownership. Concurrently, forging strategic partnerships with contract manufacturers and regional distributors can mitigate supply chain vulnerabilities and support rapid market entry in high-growth territories.

Investing in advanced informatics and artificial intelligence capabilities will enhance diagnostic accuracy and speed decision-making. By deploying cloud-based analytics, organizations can enable remote monitoring, predictive maintenance, and performance benchmarking across multi-site operations. Expanding footprint in emerging markets through localized manufacturing partnerships and regulatory collaborations can unlock new revenue streams and bolster global resilience.

Finally, embracing patient-centric service models, such as direct-to-consumer testing and telehealth integration, will differentiate service offerings and foster deeper engagement. By aligning product roadmaps with evolving reimbursement guidelines and payer expectations, companies can ensure sustained market access and drive long-term adoption across diverse healthcare settings.

Detailing the Comprehensive Research Methodology Employing Primary Interviews, Secondary Analysis, and Data Triangulation to Ensure Rigorous Market Insights

This analysis draws upon a rigorous, mixed-methods research design to ensure comprehensive coverage and analytical precision. Primary insights were gathered through structured interviews with C-suite executives, clinical laboratory directors, key opinion leaders, and procurement specialists. These conversations illuminated current operational challenges, unmet needs, and strategic priorities across the value chain.

Secondary data was meticulously compiled from peer-reviewed journals, regulatory agency publications, patent databases, company annual reports, and trade documentation. Each data point underwent triangulation to validate accuracy and minimize bias. Quantitative information was cross-referenced with historical performance indicators and industry benchmarks, while qualitative findings were synthesized through thematic analysis to identify emergent patterns.

A multi-stage validation process, including peer review by domain experts and technical stakeholders, further enhanced the reliability of the conclusions. Through these integrated research methodologies, the report delivers actionable intelligence that is grounded in empirical evidence and reflective of real-world market dynamics.

Concluding Perspectives Emphasizing Strategic Imperatives, Future Outlook, and Integrative Innovations that Will Guide the Evolution of Endocrine Testing Worldwide

The endocrine testing market stands at an inflection point, where rapid technological advancements, shifting regulatory regimes, and evolving patient expectations converge to redefine diagnostic paradigms. Segmentation analysis underscores the diverse needs of clinical laboratories, research entities, and point-of-care providers, while regional insights highlight the importance of adaptive market entry strategies.

Competitive profiling reveals that success will hinge on the ability to integrate multidisciplinary capabilities-from assay innovation and digital health integration to strategic supply chain partnerships. Actionable recommendations emphasize the need for flexible platforms, robust informatics, and targeted expansion into underserved regions.

As industry stakeholders navigate these complexities, sustained collaboration and a relentless focus on quality, compliance, and patient outcomes will dictate long-term resilience. By leveraging the insights contained herein, decision makers can chart a clear path forward, positioning their organizations to capitalize on the next wave of innovation in endocrine diagnostics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endocrine Testing Market, by Type

  • 8.1. Cortisol Test
  • 8.2. Dehydroepiandrosterone Sulfate (DHEAS) Test
  • 8.3. Estradiol (E2) Test
  • 8.4. Human Chorionic Gonadotropin (hCG) Hormone Test
  • 8.5. Insulin Test
  • 8.6. Sex Hormone Tests
  • 8.7. Thyroid Stimulating Hormone (TSH) Test

9. Endocrine Testing Market, by Product Type

  • 9.1. Instruments
    • 9.1.1. Chromatography Systems
    • 9.1.2. Immunoassay Analyzers
    • 9.1.3. Mass Spectrometry Systems
  • 9.2. Reagents & Kits
    • 9.2.1. Calibrators
    • 9.2.2. Control Materials
    • 9.2.3. Diagnostic Kits
  • 9.3. Software And Services
    • 9.3.1. Informatics Solutions
    • 9.3.2. Maintenance Services

10. Endocrine Testing Market, by Sample Type

  • 10.1. Blood
  • 10.2. Saliva
  • 10.3. Urine

11. Endocrine Testing Market, by Technology

  • 11.1. Clinical Chemistry
  • 11.2. Immunoassay
  • 11.3. Monoclonal & Polyclonal Antibody Technologies
  • 11.4. Sensor Technology
  • 11.5. Tandem Mass Spectrometry

12. Endocrine Testing Market, by Disease Type

  • 12.1. Adrenal Disorders
    • 12.1.1. Addison's Disease
    • 12.1.2. Cushing's Syndrome
  • 12.2. Diabetes
  • 12.3. Gonadal Disorders
    • 12.3.1. Hypogonadism
    • 12.3.2. Polycystic Ovary Syndrome
  • 12.4. Thyroid Dysfunction
    • 12.4.1. Hyperthyroidism
    • 12.4.2. Hypothyroidism

13. Endocrine Testing Market, by End User

  • 13.1. Academic Institutions
  • 13.2. Diagnostic Laboratories
  • 13.3. Hospitals & Clinics
  • 13.4. Research Institutes

14. Endocrine Testing Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Endocrine Testing Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Endocrine Testing Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Endocrine Testing Market

18. China Endocrine Testing Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. ACON Laboratories, Inc.
  • 19.7. Agilent Technologies, Inc.
  • 19.8. Bio-Rad Laboratories Inc
  • 19.9. BioCheck Inc.
  • 19.10. Biogenix Inc. Pvt. Ltd
  • 19.11. bioMerieux SA
  • 19.12. Blueprint Genetics Oy
  • 19.13. Creative Diagnostics
  • 19.14. Danaher Corporation
  • 19.15. Diagnostic Automation/Cortez Diagnostics Inc.
  • 19.16. DiaSorin S.p.A.
  • 19.17. Eagle Biosciences
  • 19.18. EKF Diagnostics Holdings Plc
  • 19.19. Eli Science Inc.
  • 19.20. Eurofins Analytical Laboratories Inc.
  • 19.21. F. Hoffmann-La Roche Ltd
  • 19.22. Getein Biotech, Inc.
  • 19.23. Laboratory Corporation of America Holdings
  • 19.24. MP Biomedicals, LLC
  • 19.25. Ortho-Clinical Diagnostics, Inc.
  • 19.26. Quest Diagnostics Incorporated
  • 19.27. Randox Laboratories Ltd.
  • 19.28. Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • 19.29. Siemens Healthcare GmbH
  • 19.30. Thermo Fisher Scientific Inc.
  • 19.31. Trivitron Healthcare

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. GCC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. GCC ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. GCC ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. GCC ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 257. GCC ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 259. GCC ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 265. GCC ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. G7 ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. G7 ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. G7 ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. G7 ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 296. G7 ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 297. G7 ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 298. G7 ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 300. G7 ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. G7 ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 302. G7 ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 303. G7 ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 304. G7 ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 305. NATO ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 306. NATO ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. NATO ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. NATO ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 309. NATO ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 310. NATO ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 311. NATO ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. NATO ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 313. NATO ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 315. NATO ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 316. NATO ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 317. NATO ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2